The historical rank and industry rank for Evelo Biosciences's Price-to-Tangible-Book or its related term are showing as below:
During the past 7 years, Evelo Biosciences's highest Price to Tangible Book Ratio was 37.53. The lowest was 2.16. And the median was 3.27.
EVLO's Price-to-Tangible-Book is not ranked *
in the Biotechnology industry.
Industry Median: 2.715 * Ranked among companies with meaningful Price-to-Tangible-Book only.
Evelo Biosciences Price-to-Tangible-Book Historical Data
The historical data trend for Evelo Biosciences's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Evelo Biosciences's Price-to-Tangible-Book
For the Biotechnology subindustry, Evelo Biosciences's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evelo Biosciences's Price-to-Tangible-Book Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Evelo Biosciences's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Evelo Biosciences's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Evelo Biosciences Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of Evelo Biosciences's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
Evelo Biosciences (Evelo Biosciences) Business Description
Evelo Biosciences Inc is a United States-based biotechnology company. It is engaged in discovering and developing a new class of orally delivered investigational medicines that are intended to act on cells in the small intestine to produce therapeutic effects throughout the body. Its lead product candidate under development is EDP1815, which is for the treatment of inflammatory diseases and the hyperinflammatory response associated with COVID-19. Other products in the pipeline include EDP1867 and EDP2939 for the treatment of inflammatory disease and EDP1908 for the treatment of cancer.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
EVLO has been successfully added to your 